Original Research
Accepted on 30 Jan 2026
Histopathological alterations in airways linked to physiological changes in airway allergy phenotypes
Frontiers in Allergy
814 Publications
volumes
Volume 7 - 2026
Review
Accepted on 30 Jan 2026
Recent Advances in Biologic Therapy for Chronic Rhinosinusitis
Frontiers in Allergy
Original Research
Published on 30 Jan 2026
The Spanish REAL project: expert allergist guidance on allergen immunotherapy based on mixtures from different allergenic sources
Frontiers in Allergy
doi 10.3389/falgy.2026.1736462
- 504 views
Original Research
Accepted on 28 Jan 2026
Depemokimab demonstrates efficacy in patients with type 2 asthma with comorbid CRSwNP: Phase III SWIFT-1/-2 analysis
Frontiers in Allergy
- 123 views
Review
Accepted on 26 Jan 2026
Tic disorders and allergic diseases: mechanistic links and the impact of allergy management – a narrative review
Frontiers in Allergy
- 123 views
Original Research
Accepted on 26 Jan 2026
EUFOREA Summit in Brussels 2025: Inspiring the future of allergy & respiratory care
Frontiers in Allergy
- 128 views
Original Research
Accepted on 26 Jan 2026
Using machine learning to define mepolizumab treatment response at 2 years in patients with chronic rhinosinusitis with nasal polyps
Frontiers in Allergy
- 102 views
Original Research
Published on 26 Jan 2026
Esophageal tissue immunoglobulin G4 in eosinophilic esophagitis and its correlation with serum-specific IgG4 to six foods
Frontiers in Allergy
doi 10.3389/falgy.2026.1750690
- 239 views
Original Research
Published on 23 Jan 2026
Specific IgE to tropomyosin increases the diagnostic accuracy of shrimp allergy
Frontiers in Allergy
doi 10.3389/falgy.2026.1737009
- 425 views
Mini Review
Accepted on 22 Jan 2026
Silent Invaders: The Role of MPs on Epithelium Inflammation and Damage in Airway Diseases
Frontiers in Allergy
- 206 views
Mini Review
Published on 21 Jan 2026
Clinical evaluation of pediatric olfactory disorders: a review from etiology to management
Frontiers in Allergy
doi 10.3389/falgy.2026.1741382
- 384 views
Original Research
Accepted on 20 Jan 2026
EGFR inhibitors suppress house dust mite allergen Der pII induced inflammation in monocytes and macrophages
Frontiers in Allergy
- 121 views
Review
Published on 20 Jan 2026
Biologic therapies for severe pediatric asthma: efficacy, safety, and biomarker-guided selection
Frontiers in Allergy
doi 10.3389/falgy.2026.1757445
- 550 views
Mini Review
Accepted on 19 Jan 2026
IgE, anti-IgE therapy, and regulatory T cells: new paradigms in allergic inflammation
Frontiers in Allergy
- 170 views
Original Research
Accepted on 19 Jan 2026
The association between impulse oscillometry Z-scores and asthma control and exacerbation risk in a tertiary severe asthma clinic
Frontiers in Allergy
- 119 views
Original Research
Accepted on 19 Jan 2026
Pentraxin 3 Deficiency Exacerbates Neutrophilic Inflammation and Airway Hyperresponsiveness in Type 2-Low Asthma
Frontiers in Allergy
- 222 views
Volume 6 - 2025
Original Research
Published on 29 Jan 2026
A shared metabolic-immune axis links local and systemic inflammation in chronic rhinosinusitis with comorbid asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1700350
- 376 views
Brief Research Report
Published on 29 Jan 2026
Impact of biologicals on revision ESS numbers in CRSwNP in a tertiary care rhinology center
Frontiers in Allergy
doi 10.3389/falgy.2025.1725159
- 291 views
Original Research
Published on 26 Jan 2026
A new experimental model of peanut allergy in BALB/c and C57BL/6 mice
Frontiers in Allergy
doi 10.3389/falgy.2025.1717401
- 507 views
Original Research
Published on 23 Jan 2026
Risk factors for drug resistance in allergen immunotherapy for allergic rhinitis: a systematic review and meta-analysis
Frontiers in Allergy
doi 10.3389/falgy.2025.1743260
- 538 views
Editorial
Published on 21 Jan 2026
Editorial: Exploring the interconnection: obesity's role in asthma development and management
Frontiers in Allergy
doi 10.3389/falgy.2025.1759789
- 397 views
Clinical Trial
Published on 21 Jan 2026
A randomized, double-blind, placebo-controlled trial of soluble corn fiber supplementation for children with asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1707834
- 498 views
Case Report
Published on 21 Jan 2026
Case Report: Extending dosing intervals of biologics in adults severe asthma: a case series
Frontiers in Allergy
doi 10.3389/falgy.2025.1635540
- 579 views
Original Research
Published on 21 Jan 2026
MRGPRX2-expressing mast cells are increased in the GI tract of individuals with active inflammatory bowel disease and hereditary α-tryptasemia
Frontiers in Allergy
doi 10.3389/falgy.2025.1726096
- 746 views